Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (93)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lambert, J. C.
Right arrow Articles by Chartier-Harlin, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lambert, J. C.
Right arrow Articles by Chartier-Harlin, M. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 7, 1511-1516, Copyright © 1998 by Oxford University Press

ARTICLES

Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease

JC Lambert, C Berr, F Pasquier, A Delacourte, B Frigard, D Cottel, J Perez-Tur, V Mouroux, M Mohr, D Cecyre, D Galasko, C Lendon, J Poirier, J Hardy, D Mann, P Amouyel and MC Chartier-Harlin
INSERM CJF95-05, Institut Pasteur de Lille, 1 rue du Professeur Calmette, BP 245, 59019 Lille Cedex, France.

Possession of the apolipoprotein E (APOE) epsilon4 allele is the most frequently associated genetic susceptibility factor for Alzheimer's disease (AD). Recently, new polymorphisms in the regulatory region of the APOE gene have been described. We analysed the effects of three of these mutations (-491 AT, -427 CT and Th1/E47cs) on disease risk in a large case-control study, and tested their impacts on APOE allelic expression in brain tissues. The Th1/E47cs T allele was associated with an increased risk of occurrence of AD, while the -491 T allele was associated with a decreased risk, independently of the APOE epsilon2/epsilon3/epsilon4 polymorphism effect. However, the impact of the Th1/E47cs mutation was the strongest. The -427 CT polymorphism was not associated with the disease. In AD subjects heterozygous for the epsilon4 allele, analysis of allelic expression showed that the relative expression levels of the epsilon4 allele were higher than those of the corresponding controls. Consistent with epidemiological data, the relative level of expression of the epsilon4 allele was modified accordingly to the presence or absence of the two main promoter polymorphisms, indicating, in vivo, the deleterious effect of the Th1/E47cs T allele and the protective effect of the -491 T allele in population. These data indicate that in addition to the qualitative effect of the APOE epsilon2/epsilon3/epsilon4 polymorphisms on the AD occurrence, the quantitative variation of expression of these alleles due to functional APOE promoter mutations, is a key determinant of AD development.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
O. Belbin, J. L. Dunn, Y. Ling, L. Morgan, S. Chappell, H. Beaumont, D. Warden, D. A. Smith, N. Kalsheker, and K. Morgan
Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease
Hum. Mol. Genet., September 15, 2007; 16(18): 2199 - 2208.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
B A Parmenter, D R Denney, S G Lynch, L S Middleton, and L M Harlan
Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms
Multiple Sclerosis, January 1, 2007; 13(1): 25 - 32.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Ohyama, S. Meaney, M. Heverin, L. Ekstrom, A. Brafman, M. Shafir, U. Andersson, M. Olin, G. Eggertsen, U. Diczfalusy, et al.
Studies on the Transcriptional Regulation of Cholesterol 24-Hydroxylase (CYP46A1): MARKED INSENSITIVITY TOWARD DIFFERENT REGULATORY AXES
J. Biol. Chem., February 17, 2006; 281(7): 3810 - 3820.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
J-C Lambert, D Mann, F Richard, J Tian, J Shi, U Thaker, S Merrot, J Harris, B Frigard, T Iwatsubo, et al.
Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease?
J. Neurol. Neurosurg. Psychiatry, July 1, 2005; 76(7): 928 - 933.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
B. Tycko, J. H. Lee, A. Ciappa, A. Saxena, C.-M. Li, L. Feng, A. Arriaga, Y. Stern, R. Lantigua, N. Shachter, et al.
APOE and APOC1 Promoter Polymorphisms and the Risk of Alzheimer Disease in African American and Caribbean Hispanic Individuals
Arch Neurol, September 1, 2004; 61(9): 1434 - 1439.
[Abstract] [Full Text] [PDF]

Home page
 Br J OphthalmolHome page
S Lake, E Liverani, M Desai, R Casson, B James, A Clark, and J F Salmon
Normal tension glaucoma is not associated with the common apolipoprotein E gene polymorphisms
Br J Ophthalmol, April 1, 2004; 88(4): 491 - 493.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
J-C Lambert, N Coyle, and C Lendon
The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease
J. Med. Genet., February 1, 2004; 41(2): 104 - 112.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
C Aucan, A J Walley, and A V S Hill
Common apolipoprotein E polymorphisms and risk of clinical malaria in the Gambia
J. Med. Genet., January 1, 2004; 41(1): 21 - 24.
[Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
J. Zhang, W. L. Rowe, J. P. Struewing, and K. H. Buetow
HapScope: a software system for automated and visual analysis of functionally annotated haplotypes
Nucleic Acids Res., December 1, 2002; 30(23): 5213 - 5221.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
E. S. Athan, J. H. Lee, A. Arriaga, R. P. Mayeux, and B. Tycko
Polymorphisms in the Promoter of the Human APP Gene: Functional Evaluation and Allele Frequencies in Alzheimer Disease
Arch Neurol, November 1, 2002; 59(11): 1793 - 1799.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. M. Weidenhammer, B. F. Kahl, L. Wang, L. Wang, M. Duhon, J. A. Jackson, M. Slater, and X. Xu
Multiplexed, Targeted Gene Expression Profiling and Genetic Analysis on Electronic Microarrays
Clin. Chem., November 1, 2002; 48(11): 1873 - 1882.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
K.R. Bales, J.C. Dodart, R.B. DeMattos, D.M. Holtzman, and S.M. Paul
Apolipoprotein E, Amyloid, and Alzheimer Disease
Mol. Interv., October 1, 2002; 2(6): 363 - 375.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. C. Lambert, L. Araria-Goumidi, L. Myllykangas, C. Ellis, J. C. Wang, M. J. Bullido, J. M. Harris, M. J. Artiga, D. Hernandez, J. M. Kwon, et al.
Contribution of APOE promoter polymorphisms to Alzheimer's disease risk
Neurology, July 9, 2002; 59(1): 59 - 66.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
C. HOLMES
Genotype and phenotype in Alzheimer's disease
The British Journal of Psychiatry, February 1, 2002; 180(2): 131 - 134.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
J.-C. Lambert, D. M A Mann, J. M Harris, M.-C. Chartier-Harlin, A. Cumming, J. Coates, H. Lemmon, D. StClair, T. Iwatsubo, and C. Lendon
The {-}48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased A{beta} load in brain
J. Med. Genet., June 1, 2001; 38(6): 353 - 355.
[Abstract] [Full Text]

Home page
 NeurologyHome page
J. C. Wang, J. M. Kwon, P. Shah, J. C. Morris, and A. Goate
Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease
Neurology, December 12, 2000; 55(11): 1644 - 1649.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. Theuns and C. Van Broeckhoven
Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility
Hum. Mol. Genet., October 1, 2000; 9(16): 2383 - 2394.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
D. A. Nickerson, S. L. Taylor, S. M. Fullerton, K. M. Weiss, A. G. Clark, J. H. Stengård, V. Salomaa, E. Boerwinkle, and C. F. Sing
Sequence Diversity and Large-Scale Typing of SNPs in the Human Apolipoprotein E Gene
Genome Res., October 1, 2000; 10(10): 1532 - 1545.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
I. Tesseur, J. Van Dorpe, K. Spittaels, C. Van den Haute, D. Moechars, and F. Van Leuven
Expression of Human Apolipoprotein E4 in Neurons Causes Hyperphosphorylation of Protein Tau in the Brains of Transgenic Mice
Am. J. Pathol., March 1, 2000; 156(3): 951 - 964.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. Theuns, J. Del-Favero, B. Dermaut, C. M. v. Duijn, H. Backhovens, M. V. d. Broeck, S. Serneels, E. Corsmit, C. V. Broeckhoven, and M. Cruts
Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression
Hum. Mol. Genet., February 12, 2000; 9(3): 325 - 331.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J.-C. Lambert, T. Brousseau, V. Defosse, A. Evans, D. Arveiler, J.-B. Ruidavets, B. Haas, J.-P. Cambou, G. Luc, P. Ducimetiere, et al.
Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations--the ECTIM Study
Hum. Mol. Genet., January 1, 2000; 9(1): 57 - 61.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. R. Bales, T. Verina, D. J. Cummins, Y. Du, R. C. Dodel, J. Saura, C. E. Fishman, C. A. DeLong, P. Piccardo, V. Petegnief, et al.
Apolipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer's disease
PNAS, December 21, 1999; 96(26): 15233 - 15238.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
V. M. Casadei, C. Ferri, F. Veglia, A. Gavazzi, G. Salani, M. Cattaneo, S. Sorbi, G. Annoni, F. Licastro, C. Mariani, et al.
APOE -491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease
Neurology, November 1, 1999; 53(8): 1888 - 1888.
[Full Text]

Home page
 J. Biol. Chem.Home page
E. Salero, R. Perez-Sen, J. Aruga, C. Gimenez, and F. Zafra
Transcription Factors Zic1 and Zic2 Bind and Transactivate the Apolipoprotein E Gene Promoter
J. Biol. Chem., January 12, 2001; 276(3): 1881 - 1888.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.